Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
Baird Medical (NASDAQ: BDMD) recently sponsored an advanced Microwave Ablation (MWA) training session in New Orleans, focusing on thyroid care advancement. Led by Dr. Emad Kandil from Tulane University School of Medicine, the program provided hands-on training to two endocrinologists who observed seven live MWA cases.
Dr. Kandil, who has performed over 80 MWA procedures, recently presented at the American Thyroid Association meeting, highlighting MWA's effectiveness compared to Radiofrequency Ablation. The participating physicians received Certificates of Completion, preparing them to integrate MWA into their clinical practices.
The initiative reflects Baird Medical's commitment to expanding access to minimally invasive therapies through physician education and training partnerships.
Baird Medical (NASDAQ: BDMD) ha recentemente sponsorizzato una sessione avanzata di formazione sulla Ablazione a Microonde (MWA) a New Orleans, concentrandosi sui progressi nella cura della tiroide. Guidato dal Dr. Emad Kandil della Tulane University School of Medicine, il programma ha fornito formazione pratica a due endocrinologi che hanno osservato sette casi dal vivo di MWA.
Il Dr. Kandil, che ha eseguito oltre 80 procedure di MWA, ha recentemente presentato al congresso dell'American Thyroid Association, evidenziando l'efficacia della MWA rispetto all'Ablazione a Radiofrequenza. I medici partecipanti hanno ricevuto Certificati di Completamento, preparandoli ad integrare la MWA nelle loro pratiche cliniche.
Questa iniziativa riflette l'impegno di Baird Medical nell'espandere l'accesso a terapie minimamente invasive attraverso l'educazione e le partnership di formazione per i medici.
Baird Medical (NASDAQ: BDMD) recientemente patrocinó una sesión de formación avanzada sobre Ablación por Microondas (MWA) en Nueva Orleans, centrándose en el avance del cuidado de la tiroides. Dirigido por el Dr. Emad Kandil de la Escuela de Medicina de la Universidad de Tulane, el programa ofreció capacitación práctica a dos endocrinólogos que observaron siete casos en vivo de MWA.
El Dr. Kandil, que ha realizado más de 80 procedimientos de MWA, presentó recientemente en la reunión de la Asociación Americana de Tiroides, destacando la efectividad de la MWA en comparación con la Ablación por Radiofrecuencia. Los médicos participantes recibieron Certificados de Finalización, preparándolos para integrar la MWA en sus prácticas clínicas.
La iniciativa refleja el compromiso de Baird Medical de expandir el acceso a terapias mínimamente invasivas a través de la educación de médicos y alianzas de formación.
Baird Medical (NASDAQ: BDMD)는 최근 뉴올리언스에서 갑상선 치료 발전에 중점을 둔 고급 마이크로웨이브 절제술(MWA) 교육 세션을 후원했습니다. 튤레인 대학교 의과대학의 에마드 칸딜 박사가 이끄는 이 프로그램은 7개의 실시간 MWA 사례를 관찰한 두 명의 내분비학자에게 실습 교육을 제공했습니다.
칸딜 박사는 80회 이상의 MWA 절차를 수행했으며, 미국 갑상선 협회 회의에서 MWA의 효과를 라디오주파수 절제술과 비교하여 발표했습니다. 참여 의사들은 체계적인 교육을 받으며 MWA를 임상에 통합할 수 있는 수료증을 수여받았습니다.
이 initiative는 Baird Medical의 의료진 교육 및 훈련 파트너십을 통해 최소 침습 치료의 접근성을 확대하려는 의지를 반영합니다.
Baird Medical (NASDAQ: BDMD) a récemment parrainé une session avancée de formation à l'Ablation par Micro-ondes (MWA) à La Nouvelle-Orléans, axée sur l'avancement des soins de la thyroïde. Dirigé par le Dr Emad Kandil de l'École de Médecine de l'Université de Tulane, le programme a fourni une formation pratique à deux endocrinologues qui ont observé sept cas en direct de MWA.
Le Dr Kandil, qui a réalisé plus de 80 procédures de MWA, a récemment présenté lors de la réunion de l'American Thyroid Association, mettant en avant l'efficacité de la MWA par rapport à l'Ablation par Radiofréquence. Les médecins participants ont reçu des certificats d'achèvement, les préparant à intégrer la MWA dans leurs pratiques cliniques.
Cette initiative reflète l'engagement de Baird Medical à élargir l'accès aux thérapies mini-invasives grâce à l'éducation et aux partenariats de formation pour les médecins.
Baird Medical (NASDAQ: BDMD) hat kürzlich eine fortgeschrittene Schulung zur Mikrowellenablation (MWA) in New Orleans gesponsert, die sich auf Fortschritte in der Schilddrüsenversorgung konzentrierte. Das Programm, das von Dr. Emad Kandil von der Tulane University School of Medicine geleitet wurde, bot praktische Schulungen für zwei Endokrinologen an, die sieben Live-MWA-Fälle beobachteten.
Dr. Kandil, der über 80 MWA-Verfahren durchgeführt hat, präsentierte kürzlich auf dem Treffen der American Thyroid Association und hob die Wirksamkeit der MWA im Vergleich zur Radiofrequenzablation hervor. Die teilnehmenden Ärzte erhielten Abschlusszertifikate, um sie darauf vorzubereiten, die MWA in ihre klinische Praxis zu integrieren.
Diese Initiative spiegelt das Engagement von Baird Medical wider, den Zugang zu minimalinvasiven Therapien durch die Ausbildung und Partnerschaften mit Ärzten zu erweitern.
- Expanding physician network through training programs
- Successfully conducted 7 live MWA cases during training
- Growing adoption of MWA technology in thyroid treatment
- None.
Insights
The sponsored training session, while showcasing Baird Medical's commitment to physician education, represents a routine operational update rather than market-moving news. While the training of two endocrinologists and Dr. Kandil's expertise with 80+ MWA procedures demonstrate growing adoption, this event alone is unlikely to significantly impact the company's financial performance or stock value.
The article lacks specific financial metrics, commercial milestones, or regulatory developments that would materially affect investor decision-making. Training programs, though important for long-term market penetration, are standard practice in medical device companies and typically don't constitute material news for investors.
Led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, the program welcomed Dr. Ernest O. Asamoah, an endocrinologist from
Dr. Kandil, who has performed over 80 MWA procedures, recently presented at the American Thyroid Association (ATA) annual meeting. He highlighted MWA's effectiveness compared to Radiofrequency Ablation (RFA) and shared clinical insights, stating, "MWA of thyroid nodules is a novel, safe, and effective method for treating appropriately selected patients."
The two endocrinologists also engaged in meaningful post-training discussions with Dr. Kandil, gaining further insights into the transformative potential of MWA. Both physicians received Certificates of Completion, marking their enhanced proficiency and readiness to integrate MWA into their clinical practices.
"Investing in physician education is key to improving patient outcomes and expanding access to innovative treatments like MWA," said Haimei Wu, Chairwoman of Baird Medical. "By partnering with expert practitioners like Dr. Kandil, we empower clinicians to expand treatment options and improve outcomes in their communities."
Through targeted training programs, Baird Medical supports the adoption of innovative, minimally invasive therapies. These initiatives aim to connect expertise with technology, helping to expand access to patient-focused solutions and contribute to improved thyroid care outcomes.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-sponsored-microwave-ablation-training-advances-innovation-in-thyroid-care-302332248.html
SOURCE BDMD
FAQ
What was the outcome of Baird Medical's (BDMD) recent MWA training session in New Orleans?
How many MWA procedures has Dr. Kandil performed for Baird Medical (BDMD)?
What are the advantages of Baird Medical's (BDMD) MWA technology for thyroid treatment?
How is Baird Medical (BDMD) expanding access to MWA technology?
